§ 26.1-36-09.14 — Coverage of cancer treatment medications

North Dakota § 26.1-36-09.14

• Jurisdiction: North Dakota
• Title 26.1: Insurance
• Ch. 26.1-36: Accident and Health Insurance

Text

1. As used in this section:
a. "Cancer treatment medications" means prescription drugs and biologics that are
used to kill, slow, or prevent the growth of cancerous cells.
b. "Insurer" means an insurance company, nonprofit health service corporation, or
health maintenance organization.
c. "Patient-administered" includes oral administration and self-injection.
d. "Policy" means an accident and health insurance policy, contract, or evidence of
coverage on a group, individual, blanket, franchise, or association basis.

2. An insurer may not deliver, issue, execute, or renew a policy that provides coverage
for cancer treatment medications that are injected or are intravenously administered by
a health care provider and that provides coverage for patient-administered cancer
treatment medications unless the policy copayment, deductible, and coinsurance
amounts for patient-administered cancer treatment medications do not exceed the
amounts for cancer treatment medications that are injected or are intravenously
administered by a health care provider, regardless of the formulation or benefit
category.
3. An insurer may not increase a copayment, deductible, or coinsurance amount for
covered cancer treatment medications that are injected or intravenously administered
in order to avoid compliance with subsection 2. An insurer may not reclassify benefits
with respect to cancer treatment medications in a manner that is inconsistent with this
section.